Atrial Fibrillation and Cardiac Arrhythmias

Atrial fibrillation (AFib) is the most common sustained cardiac arrhythmia encountered in clinical cardiology, affecting an estimated 33 million people worldwide according to the Global Burden of Disease Study. This page covers the classification of cardiac arrhythmias, the electrophysiological mechanisms that produce abnormal heart rhythms, the clinical scenarios in which arrhythmias present, and the diagnostic and treatment decision boundaries that govern management. Understanding the scope of these conditions matters because AFib alone is associated with a 5-fold increased risk of ischemic stroke, placing it among the most consequential arrhythmias in cardiovascular medicine (American Heart Association).

Definition and scope

A cardiac arrhythmia is any abnormality in the rate, regularity, or conduction pathway of the heart's electrical activation sequence. The American College of Cardiology (ACC) and American Heart Association (AHA) classify arrhythmias along two primary axes: anatomical origin and functional consequence.

By anatomical origin:
- Supraventricular arrhythmias — originate above the bundle of His; include AFib, atrial flutter, supraventricular tachycardia (SVT), and atrial premature complexes
- Ventricular arrhythmias — originate in the ventricular myocardium or His-Purkinje system; include premature ventricular contractions (PVCs), ventricular tachycardia (VT), and ventricular fibrillation (VF)
- Conduction system disorders — include sinoatrial node dysfunction (sick sinus syndrome) and atrioventricular (AV) block of varying degrees

By functional consequence:
- Tachyarrhythmias — heart rate exceeding 100 beats per minute (bpm)
- Bradyarrhythmias — heart rate below 60 bpm with hemodynamic compromise
- Life-threatening arrhythmias — VF and pulseless VT require immediate defibrillation per Advanced Cardiac Life Support (ACLS) guidelines published by the AHA

Atrial fibrillation itself carries a sub-classification. The 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation defines four temporal patterns: first-detected, paroxysmal (self-terminating within 7 days), persistent (lasting more than 7 days), and long-standing persistent (continuous for 12 months or longer). A fifth category, permanent AFib, designates cases where rhythm control is no longer pursued by clinical consensus.

The Centers for Disease Control and Prevention (CDC) estimates that 12.1 million people in the United States will have AFib by 2030, making arrhythmia management one of the central challenges in the broader regulatory and clinical framework governing cardiology practice.

How it works

Normal cardiac rhythm begins at the sinoatrial (SA) node, a cluster of specialized pacemaker cells in the right atrium. The SA node fires at 60–100 bpm under resting conditions, propagating an electrical impulse through the atrial myocardium to the atrioventricular (AV) node, then down the bundle of His, through the right and left bundle branches, and finally to the Purkinje fiber network — producing synchronized ventricular contraction.

Arrhythmias disrupt this sequence through three primary electrophysiological mechanisms:

  1. Abnormal automaticity — Ectopic foci outside the SA node fire spontaneously, either due to enhanced normal automaticity (e.g., ischemia-driven PVCs) or triggered activity from after-depolarizations (common in digitalis toxicity and long QT syndrome)
  2. Re-entry circuits — The most prevalent mechanism in both AFib and atrial flutter. A wavefront of electrical activation loops back through tissue that has recovered excitability, sustaining a self-perpetuating circuit. In AFib, multiple simultaneous re-entry wavelets produce chaotic atrial activation at 350–600 impulses per minute
  3. Conduction block — Failure of normal impulse transmission, as in second-degree and third-degree AV block, produces bradycardia or AV dissociation

In AFib specifically, the AV node acts as a gatekeeper, blocking the majority of atrial impulses and producing the characteristically irregular ventricular response seen on a 12-lead electrocardiogram (ECG/EKG). The absence of coordinated atrial contraction reduces ventricular filling by approximately 20–30%, and blood stasis in the left atrial appendage (LAA) creates a substrate for thrombus formation — the primary mechanism behind AFib-related embolic stroke.

Stroke risk in AFib is stratified using the CHA₂DS₂-VASc scoring system, endorsed by the 2023 ACC/AHA/ACCP/HRS guidelines. A score of 2 or greater in males and 3 or greater in females triggers a recommendation for oral anticoagulation.

Common scenarios

Arrhythmias present across a wide spectrum of clinical contexts. The five most frequently encountered scenarios in outpatient and inpatient cardiology are:

  1. Incidental discovery on routine ECG — Paroxysmal AFib or first-degree AV block identified during pre-operative screening or occupational health examination in a patient with no symptoms
  2. Palpitations with exertion — SVT or exercise-induced PVCs in a structurally normal heart; ambulatory monitoring via a Holter monitor or event recorder is the standard diagnostic next step
  3. Syncope or presyncope — High-degree AV block or sick sinus syndrome causing hemodynamically significant pauses; requires urgent evaluation for pacemaker implantation
  4. Post-operative new-onset AFib — Occurs in approximately 20–40% of patients following cardiac surgery, per data cited in AHA scientific statements, and typically requires rate control and short-term anticoagulation
  5. Out-of-hospital cardiac arrest — VF is the initiating rhythm in approximately 70–80% of sudden cardiac arrests, per AHA Heart Disease and Stroke Statistics; implantable cardioverter-defibrillators (ICDs) are the primary prevention tool in high-risk patients

Patients with known structural heart disease — including heart failure with reduced ejection fraction (HFrEF) below 35% — face compounded arrhythmia risk and require integrated management across the cardiology spectrum described across cardiologyauthority.com.

Decision boundaries

The management pathway for any arrhythmia depends on four decision boundaries that clinicians evaluate sequentially:

1. Hemodynamic stability
Unstable patients (hypotension, altered consciousness, acute pulmonary edema) require immediate electrical cardioversion regardless of arrhythmia type, per ACLS protocols. Stable patients proceed to rhythm characterization.

2. Rhythm control versus rate control in AFib
The AFFIRM trial (published in the New England Journal of Medicine, 2002) established that rate control is non-inferior to rhythm control for mortality in persistent AFib in older patients. The 2023 ACC/AHA guidelines now favor early rhythm control — particularly cardiac ablation — in symptomatic patients under 65 or those with heart failure, given data from the EAST-AFNET 4 trial showing a 21% reduction in cardiovascular death, stroke, or worsening heart failure with early rhythm control.

3. Anticoagulation threshold
CHA₂DS₂-VASc scores determine anticoagulation eligibility. Direct oral anticoagulants (DOACs) — including apixaban, rivaroxaban, and dabigatran — are preferred over warfarin in non-valvular AFib per the 2023 guidelines based on superior bleeding profiles in randomized trials. Valvular AFib (specifically in mitral stenosis or mechanical valve patients) requires warfarin.

4. Device therapy eligibility
The threshold for ICD implantation in primary prevention is a left ventricular ejection fraction (LVEF) ≤ 35% despite at least 3 months of guideline-directed medical therapy, consistent with ACC/AHA Heart Failure Guidelines. Bradyarrhythmias meeting symptomatic or electrographic criteria for pacemaker implantation are governed by the same ACC/AHA guidelines framework and require documentation of correlation between symptoms and rhythm.

The boundary between electrophysiology specialist management and general cardiology management is defined by complexity: ablation procedures, device implantation, and channelopathy evaluation (e.g., Brugada syndrome, long QT syndrome) fall within electrophysiology fellowship-trained subspecialty practice.

References

- American Heart Association — Atrial Fibrillation

The law belongs to the people. Georgia v. Public.Resource.Org, 590 U.S. (2020)